Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LeoDOR: Repetitive Levosimendan in Advanced Heart Failure
NCT03437226Phase 3Unknown
- Start
- Mar 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in heart failure (HF). Status: unknown.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03437226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03437226.